WASHINGTON, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTIONS FOUNDATION, founded in 1978, is a mid-sized nonprofit that reported $12.6M in total revenue in fiscal year 2023. Revenue grew 15% year-over-year, indicating healthy expansion. Expenses of $11.7M left a modest 7% surplus.
THE SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTIONS FOUNDATION (THE FOUNDATION) PROMOTES EXCELLENCE IN INVASIVE AND INTERVENTIONAL CARDIOVASCULAR MEDICINE THROUGH PHYSICIAN EDUCATION AND REPRESENTATION, AND THE ADVANCEMENT OF QUALITY STANDARDS TO ENHANCE PATIENT CARE.EMPHASIS IS PLACED ON REGISTRATION OF ALL PROCEDURES PERFORMED BY MEMBERS, DEVELOPMENT OF QUALITY STANDARDS FOR LABORATORIES, ESTABLISHMENT OF CRITERIA FOR CREDENTIALING PHYSICIANS AND DIRECTORS AND PRESENTATION OF GUIDELINES FOR TRAINING IN CARDIAC CARDIOVASCULAR ANGIOGRAPHY. FOCUS AREAS FOR THE FOUNDATION INCLUDE ESTABLISHING STANDARDS AND GUIDELINES FOR ALL ASPECTS OF CARDIAC CARDIOVASCULAR ANGIOGRAPHY, TRAINING, CREDENTIALING, SAFETY, AND QUALITY ASSURANCE FOR CARDIAC PROCEDURES.
AS THE ONLY INTERVENTIONAL CARDIOLOGY SOCIETY IN THE US, SCAI IS DEDICATED TO EQUIPPING YOU WITH TOOLS AND RESOURCES TO SUCCEED AND DELIVER TOP-NOTCH CARE TO IMPROVE THE PATIENT EXPERIENCE.
THE SCIENTIFIC SESSIONS MEETING IS AN EXTRAORDINARY GATHERING OF CARDIOVASCULAR EXPERTS THAT COME TOGETHER TO SHARE BEST PRACTICES AND CLINICAL TECHNIQUES, LEARN ABOUT THE LATEST INDUSTRY TRENDS AND...
THE SCIENTIFIC SESSIONS MEETING IS AN EXTRAORDINARY GATHERING OF CARDIOVASCULAR EXPERTS THAT COME TOGETHER TO SHARE BEST PRACTICES AND CLINICAL TECHNIQUES, LEARN ABOUT THE LATEST INDUSTRY TRENDS AND NETWORK WITH THEIR PEERS. THE EVENT IS UNIQUE TO ANY OTHER BECAUSE OF ITS COMPREHENSIVE AND UNBIASED PROGRAMMING. A DISTINGUISHED FACULTY CONDUCTS A THREE-DAY PROGRAM THAT INCLUDES LIVE CASES, FEATURED SPEAKERS, CASE REVIEWS, LECTURES, INTERACTIVE DISCUSSIONS, ABSTRACT PRESENTATIONS, POSTER SESSIONS AND MORE.
SCAI'S FELLOWS COURSES TEACH FUTURE GENERATIONS OF INTERVENTIONAL CARDIOLOGISTS THE KNOWLEDGE AND SKILLS THEY NEED FOR POST-FELLOWSHIP PRACTICE. THE COURSE WILL PROVIDE AN ENGAGING, INFORMAL, AND...
SCAI'S FELLOWS COURSES TEACH FUTURE GENERATIONS OF INTERVENTIONAL CARDIOLOGISTS THE KNOWLEDGE AND SKILLS THEY NEED FOR POST-FELLOWSHIP PRACTICE. THE COURSE WILL PROVIDE AN ENGAGING, INFORMAL, AND RELAXING ENVIRONMENT IN WHICH CARDIOLOGY FELLOWS IN TRAINING CAN INTERACT WITH INTERNATIONAL RECOGNIZED FACULTY. ATTENDEES OF THE COURSE WILL GAIN AN IN-DEPTH KNOWLEDGE OF INDICATIONS, TECHNIQUES AND EXPECTED OUTCOMES FOR INTERVENTIONAL CARDIAC, CAROTID, AND ENDOVASCULAR PROCEDURES. THE PROGRAM REPRESENTS AA VARIETY OF CLINICAL CASE-BASED CONTENT AS WELL AS MATERIAL OF IMMEDIATE VALUE TO ATTENDEES AS THEY PLAN THEIR POST-FELLOWSHIP PRACTICES. SCAI FELLOWS COURSES GIVES THE OPPORTUNITY TO LEARN FROM THE VERY BEST CLINICAL FACULTY.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $12,610,594 | $10,959,522 | +0.2% |
| Expenses | $11,724,439 | $10,191,874 | +0.2% |
| Net Income | $886,155 | $767,648 | +0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| SUNIL V RAO MD FSCAI | PAST PRESIDENT | 0.30 |
Officer
Director
|
$0 | $0 | $0 |
| TIMOTHY HENRY | PAST PRESIDENT - UNTIL 05/23 | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| GEORGE DANGAS MD MSCAI | PRESIDENT | 0.30 |
Officer
Director
|
$0 | $0 | $0 |
| JAMES HERMILLER MD MSCAI | PRESIDENT ELECT | 0.30 |
Officer
Director
|
$0 | $0 | $0 |
| ARNOLD SETO MD MPA FSCAI | TREASURER | 0.30 |
Officer
Director
|
$0 | $0 | $0 |
| SRIHARI S NAIDU MD FSCAI | VICE PRESIDENT | 0.30 |
Officer
Director
|
$0 | $0 | $0 |
| J DAWN ABBOTT MD FSCAI | SECRETARY - AS OF 05/23 | 0.30 |
Officer
Director
|
$0 | $0 | $0 |
| MIRVAT ALASNAG MD FSCAI | TRUSTEE | 0.30 |
Director
|
$0 | $0 | $0 |
| JOAQUINE E CIGARROA MD FSCAI | TRUSTEE | 0.30 |
Director
|
$0 | $0 | $0 |
| RAMESH DAGGUBATI MD FSCAI | TRUSTEE - UNTIL 09/23 | 0.50 |
Director
|
$0 | $0 | $0 |
| THOMAS E FAGAN MD MSCAI | TRUSTEE | 0.30 |
Director
|
$0 | $0 | $0 |
| FRANK J HILDNER MD FSCAI | TRUSTEE FOR LIFE | 0.30 |
Director
|
$0 | $0 | $0 |
| DANIEL M KOLANSKY MD FSCAI | TRUSTEE | 0.30 |
Director
|
$0 | $0 | $0 |
| ALEXANDRA J LANSKY MD FSCAI | TRUSTEE, EDITOR-IN-CHIEF | 1.00 |
Director
|
$100,000 | $0 | $100,000 |
| KUSUM LATA MD FSCAI | TRUSTEE | 0.30 |
Director
|
$0 | $0 | $0 |
| BINITA SHAH MD FSCAI | TRUSTEE | 0.30 |
Director
|
$0 | $0 | $0 |
| WILLIAM C SHELDON MD FSCAI | TRUSTEE FOR LIFE | 0.30 |
Director
|
$0 | $0 | $0 |
| RAJESH SWAMINATHAN MD FSCAI | TRUSTEE | 0.30 |
Director
|
$0 | $0 | $0 |
| MOLLY SZERLIP MD FSCAI | TRUSTEE | 0.30 |
Director
|
$0 | $0 | $0 |
| GORAN STANKOVIC MD FSCAI | TRUSTEE | 0.30 |
Director
|
$0 | $0 | $0 |
| FRANCESCA DEA | CHIEF EXECUTIVE OFFICER | 37.50 |
Officer
|
$396,869 | $64,914 | $461,783 |
| KATHIE H CLEARY | VP FINANCE & ADMINISTRATION | 37.50 |
Officer
|
$232,890 | $40,149 | $273,039 |
| ERIC GRAMMER | VP INDUSTRY RELATIONS | 37.50 |
Key Emp
|
$234,359 | $56,630 | $290,989 |
| ROBERT BARTEL VP OF EDUCATION | PUBLICATIONS AND QUALITY | 37.50 |
Key Emp
|
$256,231 | $37,528 | $293,759 |
| CURTIS ROONEY | VP GOVERNMENT RELATIONS | 37.50 |
Highest
|
$222,211 | $60,250 | $282,461 |
| CHRISTINE TRIMMER | VP MEMBERSHIP AND MARKETING | 37.50 |
Highest
|
$221,721 | $25,481 | $247,202 |
| JUSTIN ZIELKE | DIRECTOR OF MARKETING | 37.50 |
Highest
|
$147,297 | $21,536 | $168,833 |
| SANDY HUNG | DIRECTOR INDUSTRY RELATIONS | 37.50 |
Highest
|
$142,588 | $25,214 | $167,802 |
| JUSTINE MASCARENHAS | DIRECTOR, SCIENTIFIC PROGRAMS | 40.00 |
Highest
|
$145,209 | $24,631 | $169,840 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $12,610,594 | $11,724,439 | $15,354,615 | $886,155 |
| 2022 | $10,959,522 | $10,191,874 | $14,360,879 | $767,648 |
| 2021 | $10,722,601 | $7,750,235 | $13,648,207 | $2,972,366 |
| 2020 | $7,373,071 | $6,348,777 | $11,082,796 | $1,024,294 |
| 2019 | $10,884,292 | $9,335,770 | $9,750,042 | $1,548,522 |
| 2018 | $9,622,361 | $8,475,695 | $7,646,248 | $1,146,666 |
Compare SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTIONS FOUNDATION with other nonprofits in District of Columbia and across the country.